Back | Next |
home / stock / hils / hils message board
Subject | By | Source | When |
---|---|---|---|
Price gaining up | harry crumb | investorshub | 04/11/2023 9:47:46 AM |
$HILS should we be shorting? | Triple nickle | investorshub | 04/11/2023 5:04:53 AM |
$HILS great news | TheFinalCD | investorshub | 04/11/2023 1:15:31 AM |
$HILS The now | harry crumb | investorshub | 04/10/2023 10:44:55 PM |
$HILS The trading last up | harry crumb | investorshub | 04/10/2023 8:32:14 PM |
Price trading last trade up | harry crumb | investorshub | 04/10/2023 4:57:19 PM |
$HILS Time for this to show some returns | velcro | investorshub | 04/10/2023 8:13:18 AM |
$HILS Lets go go go go... Up up and away we go. | harry crumb | investorshub | 04/10/2023 8:02:52 AM |
just the news we needed | Runners123 | investorshub | 04/09/2023 4:53:26 PM |
$HILS Price now | harry crumb | investorshub | 04/09/2023 3:44:45 PM |
MomentumIts trading last trade up | harry crumb | investorshub | 04/09/2023 10:36:36 AM |
news all the way baby | subslover | investorshub | 04/09/2023 10:15:30 AM |
short squeeze signal | bud_fox | investorshub | 04/09/2023 5:53:28 AM |
what does this mean? | Pedro2004 | investorshub | 04/09/2023 4:46:28 AM |
$HILS Price trading last trade up | tw0122 | investorshub | 04/09/2023 4:24:49 AM |
what do you make of this data? | subslover | investorshub | 04/09/2023 12:04:43 AM |
we got news | Triple nickle | investorshub | 04/08/2023 9:07:31 PM |
What do you make of this? | subslover | investorshub | 04/08/2023 5:44:12 PM |
should we be shorting? | subslover | investorshub | 04/08/2023 12:30:09 PM |
When is this gonna take off? | harry crumb | investorshub | 04/08/2023 4:59:26 AM |
News, Short Squeeze, Breakout and More Instantly...
Hillstream BioPharma Inc. Company Name:
HILS Stock Symbol:
NASDAQ Market:
Expects to launch and complete a Phase 1 trial in Q4 2023 Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023 BRIDGEWATER, NJ / ACCESSWIRE / September 22, 2023 / Hillstream BioPharma Inc., (NASDAQ:HILS), a biotechnology company developing innovative therapeu...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic prur...